Feng-Hua Wang (Feng Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 34

Top Venues

Nature medicine

Nature communications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer communications (London, England)

Sun Yat-Sen University cancer center

Sun Yat-sen University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sun Yat-Sen University cancer center Jan 01 2018

China

Vice Director, Associate Professor :: MEDICAL ONCOLOGY

Education History

Sun Yat-sen University

China

MSC :: Oncology

University of Texas MD Anderson Cancer Center

United States

PHD :: Biomedical Sciences

Publications

Feng-Hua Wang, Lin Shen, Weijian Guo, Tian-Shu Liu, Jin Li, Shukui Qin, Yuxian Bai, Zhendong Chen, Jufeng Wang, Yue-Yin Pan, Yongqian Shu, Fuyou Zhao, Ying Cheng, Feng Ye, Kangsheng Gu, Tao Zhang, Hongming Pan, Haijun Zhong, Fuxiang Zhou, Yanru Qin, Lei Yang, Weidong Mao, Qiu Li, Wenxiang Dai, Wei Li, Shubin Wang, Yong Tang, Dong Ma, Xianli Yin, Yanhong Deng, Ying Yuan, Man Li, Wenwei Hu, Donghui Chen, Guoxin Li, Qiqi Liu, Panfeng Tan, Songhua Fan, Michael Shi, Weiguo Su, Rui-Hua Xu
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine (2024)
Shixiang Wang, Chen-Yi Wu, Ming-Ming He, Jia-Xin Yong, Yan-Xing Chen, Li-Mei Qian, Jin-Ling Zhang, Zhao-Lei Zeng, Rui-Hua Xu, Feng-Hua Wang, Qi Zhao
Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer. Nature communications 15 (1) (2024)
Feng-Hua Wang, Lin Shen, Weijian Guo, Tian-Shu Liu, Jin Li, Shukui Qin, Yuxian Bai, Zhendong Chen, Jufeng Wang, Yue-Yin Pan, Yongqian Shu, Fuyou Zhao, Ying Cheng, Feng Ye, Kangsheng Gu, Tao Zhang, Hongming Pan, Haijun Zhong, Fuxiang Zhou, Yanru Qin, Lei Yang, Weidong Mao, Qiu Li, Wenxiang Dai, Wei Li, Shubin Wang, Yong Tang, Dong Ma, Xianli Yin, Yanhong Deng, Ying Yuan, Man Li, Wenwei Hu, Donghui Chen, Guoxin Li, Qiqi Liu, Panfeng Tan, Songhua Fan, Michael Shi, Weiguo Su, Rui-Hua Xu
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial. Nature medicine 30 (8) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Feng-Hua Wang, Lin Shen, Weijian Guo, Tian-Shu Liu, Jin Li, Shukui Qin, Yuxian Bai, Zhendong Chen, Jufeng Wang, Yue-Yin Pan, Yongqian Shu, Fuyou Zhao, Ying Cheng, Feng Ye, Kangsheng Gu, Tao Zhang, Hongming Pan, Haijun Zhong, Fuxiang Zhou, Yanru Qin, Lei Yang, Weidong Mao, Qiu Li, Wenxiang Dai, Wei Li, Shubin Wang, Yong Tang, Dong Ma, Xianli Yin, Yanhong Deng, Ying Yuan, Man Li, Wenwei Hu, Donghui Chen, Guoxin Li, Qiqi Liu, Panfeng Tan, Songhua Fan, Michael Shi, Weiguo Su, Rui-Hua Xu
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial. Nature medicine 30 (8) (2024)
Shixiang Wang, Chen-Yi Wu, Ming-Ming He, Jia-Xin Yong, Yan-Xing Chen, Li-Mei Qian, Jin-Ling Zhang, Zhao-Lei Zeng, Rui-Hua Xu, Feng-Hua Wang, Qi Zhao
Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer. Nature communications 15 (1) (2024)
Feng-Hua Wang, Ying Jin, Min Wang, Hui-Yan Luo, Wei-Jia Fang, Ying-Nan Wang, Yan-Xing Chen, Run-Jie Huang, Wen-Long Guan, Weiwei Xiao, Yu-Hong Li, Feng-Hua Wang, Xiao-Hua Hu, Yan-Qiao Zhang, Miao-Zhen Qiu, Lu-Lu Liu, Zi-Xian Wang, Chao Ren, De-Shen Wang, Dong-Sheng Zhang, Zhi-Qiang Wang, Wen-Ting Liao, Lin Tian, Qi Zhao, Rui-Hua Xu
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial. Nature medicine 30 (4) (2024)
Ying Jin, Run-Jie Huang, Wen-Long Guan, Zhi-Qiang Wang, Zong-Jiong Mai, Yu-Hong Li, Jian Xiao, Xing Zhang, Qi Zhao, Shi-Fu Chen, Ming Liu, Yan-Xia Shi, Feng-Hua Wang, Rui-Hua Xu
A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation. Signal transduction and targeted therapy 9 (1) (2024)
Shixiang Wang, Chen-Yi Wu, Ming-Ming He, Jia-Xin Yong, Yan-Xing Chen, Li-Mei Qian, Jin-Ling Zhang, Zhao-Lei Zeng, Rui-Hua Xu, Feng-Hua Wang, Qi Zhao
Machine learning-based extrachromosomal DNA identification in large-scale cohorts reveals its clinical implications in cancer. Nature communications 15 (1) (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine (2024)
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Rui Jian, Xiao-Wei Sun, Ying-Bo Chen, Wen-Long Guan, Zi-Xian Wang, Hai-Bo Qiu, Wei Wang, Shi Chen, Dong-Sheng Zhang, Yi-Hong Ling, Shao-Yan Xi, Mu-Yan Cai, Chun-Yu Huang, Qiu-Xia Yang, Zhi-Min Liu, Yuan-Xiang Guan, Yong-Ming Chen, Weiwei Xiao, Xiong-Wen Tang, Jun-Sheng Peng, Zhou-Wei Zhou, Rui-Hua Xu, Feng-Hua Wang
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nature medicine 30 (2) (2024)
Bin Zhang, Chun-Mei Wang, Hao-Xiang Wu, Feng-Hua Wang, Yang-Yang Chai, Ye Hu, Bing-Jing Wang, Zhou Yu, Rong-Hua Xia, Rui-Hua Xu, Xue-Tao Cao
MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response. Cancer communications (London, England) (2023)
Jiajia Hu, Runjie Huang, Chengcai Liang, Yingnan Wang, Min Wang, Yanxing Chen, Chenyi Wu, Jinling Zhang, Zekun Liu, Qi Zhao, Ze-Xian Liu, Feng-Hua Wang, Shu-Qiang Yuan
TRIM50 inhibits gastric cancer progression by regulating the ubiquitination and nuclear translocation of JUP. Molecular cancer research : MCR (2023)
Hao-Xiang Wu, Yi-Qian Pan, Zi-Xian Wang, Feng-Hua Wang
Reply to G. Yu et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shu-Qiang Yuan, Run-Cong Nie, You-Sheng Huang, Ying-Bo Chen, Si-Yu Wang, Xiao-Wei Sun, Yuan-Fang Li, Ze-Kun Liu, Yan-Xing Chen, Yi-Chen Yao, Yu Xu, Hai-Bo Qiu, Yao Liang, Wei Wang, Ze-Xian Liu, Qi Zhao, Rui-Hua Xu, Zhi-Wei Zhou, Feng-Hua Wang
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer. Cancer communications (London, England) (2023)
Yan-Xing Chen, Zi-Xian Wang, Shu-Qiang Yuan, Teng-Jia Jiang, You-Sheng Huang, Rui-Hua Xu, Feng-Hua Wang, Qi Zhao
POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy. Clinical and translational medicine 11 (9) (2022)
Hao-Xiang Wu, Yi-Qian Pan, Ye He, Zi-Xian Wang, Wen-Long Guan, Yan-Xing Chen, Yi-Chen Yao, Ning-Yi Shao, Rui-Hua Xu, Feng-Hua Wang
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Feng-Hua Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Yingying Shi, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Ying-Nan Wang, Dan-Yun Ruan, Zi-Xian Wang, Kai Yu, Dai-Lin Rong, Ze-Xian Liu, Feng-Hua Wang, Jia-Jia Hu, Ying Jin, Qi-Nian Wu, Heng-Ying Pu, Min Wang, Rui-Hua Xu, Zhao-Lei Zeng
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc. Oncogene 41 (49) (2022)
Chen-Hui Cao, Han Ling, Kai Han, Xiao-Peng Lu, Mu-Yan Cai, Jing-Hua Cao, Jie Zhou, Zhi-Cheng Xiang, Jie-Wei Chen, Si Li, Jin-Long Lin, Jin-Ling Duan, Jie Luo, Yu-Jing Fang, Zhi-Zhong Pan, Li Liang, Feng-Hua Wang, Dan Xie, Feng-Wei Wang
PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair. Oncogene 40 (49) (2021)
Ming-Ming He, Zhe Fang, Dong Hang, Feng-Hua Wang, Georgios Polychronidis, Liang Wang, Chun-Han Lo, Kai Wang, Rong Zhong, Markus D Knudsen, Scott G Smith, Rui-Hua Xu, Mingyang Song
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank. International journal of cancer 148 (8) (2020)
Qi Zhao, Yan-Xing Chen, Qi-Nian Wu, Chao Zhang, Min Liu, Ying-Nan Wang, Yan-Fen Feng, Jia-Jia Hu, Jian-Hua Fu, Hong Yang, Jing-Jing Qi, Zi-Xian Wang, Yun-Xin Lu, Hui Sheng, Ze-Xian Liu, Zhi-Xiang Zuo, Jian Zheng, Jing-Ping Yun, Jin-Xin Bei, Wei-Hua Jia, Dong-Xin Lin, Rui-Hua Xu, Feng-Hua Wang
Systematic analysis of the transcriptome in small-cell carcinoma of the oesophagus reveals its immune microenvironment. Clinical & translational immunology 9 (10) (2020)
De-Sheng Wang, Zhi-Qiang Wang, Gong Chen, Jie-Wen Peng, Wei Wang, Yan-Hong Deng, Feng-Hua Wang, Jian-Wei Zhang, Han-Lin Liang, Fen Feng, Chuan-Bo Xie, Chao Ren, Ying Jin, Si-Mei Shi, Wen-Hua Fan, Zhen-Hai Lu, Pei-Rong Ding, Feng Wang, Rui-Hua Xu, Yu-Hong Li
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer. Cancer medicine 9 (1) (2019)
Furong Liu, Chao Ren, Ying Jin, Shaoyan Xi, Caiyun He, Fang Wang, Zixian Wang, Rui-Hua Xu, Feng-Hua Wang
Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer. Virchows Archiv : an international journal of pathology 476 (3) (2019)

Feng-Hua Wang (Feng Wang)

Publication Activity (10 Years)

Top Topics

Top Venues